Runway Growth Finance Corp. (RWAY) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates a positive sentiment overall, with strong financial performance, optimistic product development updates, and a shareholder return plan involving a stock repurchase program. Despite some muted market outlooks and competitive pressures, the Q&A section reflects a positive sentiment from analysts, especially regarding the SWK merger's accretive potential. The strategic plan and capital management efforts further support a positive outlook for the stock price in the short term.
Key Financial Performance
Total Investment Income $36.7 million, an increase from $35.1 million in the second quarter of 2025. The increase is attributed to elevated prepayment income.
Net Investment Income $15.7 million, an increase from $13.9 million in the second quarter of 2025. The increase is attributed to elevated prepayment income.
Fair Value of Total Investment Portfolio $946 million, a decrease of 7.7% from $1.02 billion in the second quarter of 2025. The decrease is due to repayments and scheduled amortization.
Net Assets $489.5 million, a decrease from $498.9 million at the end of the second quarter of 2025. The decrease is attributed to net realized losses and other factors.
Net Asset Value (NAV) per Share $13.55, a decrease of 1.9% compared to $13.66 at the end of the second quarter of 2025. The decrease is attributed to net realized losses and other factors.
Debt Portfolio Yield 16.8% for the third quarter of 2025, an increase from 15.4% in the second quarter of 2025 and 15.9% in the comparable period last year. The increase is due to elevated prepayment income and portfolio adjustments.
Operating Expenses $21 million, a slight decrease from $21.2 million in the second quarter of 2025. The decrease is attributed to cost management efforts.
Repayments $199.7 million during the third quarter of 2025, contributing to the decrease in the total investment portfolio.
Loan-to-Value Ratio 31.4%, an increase from 29.6% in the second quarter of 2025. The increase reflects portfolio adjustments.
Leverage Ratio 0.92x, a decrease from 1.05x at the end of the second quarter of 2025. The decrease is attributed to portfolio adjustments and repayments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Investments: Completed 11 investments in new and existing portfolio companies, totaling $128.3 million in funded loans. This includes $10 million investments in federal hearings and appeals services and DigiCert Inc.
Portfolio Expansion: Acquisition of SWK Holdings, scaling the portfolio by an estimated $242 million and increasing exposure in healthcare and life sciences to 31% of the portfolio.
Market Positioning: Integration within the BC Partners Credit ecosystem enhances origination channels and portfolio optimization. Acquisition of SWK Holdings positions Runway as a serious participant in venture and growth lending markets.
Portfolio Risk Management: Enhanced risk profile through diversification and smaller position sizes. Portfolio structured with 97% floating rate assets and first lien senior secured loans.
Financial Performance: Generated $36.7 million in total investment income and $15.7 million in net investment income for Q3 2025. Weighted average portfolio risk rating increased to 2.42.
Inorganic Growth Strategy: Acquisition of SWK Holdings to expand healthcare and life sciences investments, providing minimally dilutive financing to small and midsized healthcare companies.
Dividend and Shareholder Returns: Maintained $0.33 per share dividend and repurchased 397,983 shares under the stock repurchase program.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: Uncertainties surrounding interest rates and changing economic conditions could adversely impact the company's performance.
Portfolio Risk: The weighted average portfolio risk rating increased from 2.33 to 2.42, indicating a slight deterioration in credit quality.
Loan-to-Value Ratio: The loan-to-value ratio increased from 29.6% to 31.4%, suggesting higher leverage and potential risk exposure.
Nonaccrual Loan: One loan to Mingle Healthcare is on nonaccrual status, with a fair market value of only 50% of its cost, representing a potential loss.
Net Asset Value (NAV): NAV per share decreased by 1.9% from $13.66 to $13.55, reflecting a decline in shareholder value.
Repayments Impact: The portfolio experienced $199.7 million in repayments, which could impact earnings power and dividend coverage.
Regulatory Delays: The ongoing government shutdown is expected to delay SEC regulatory approval for the SWK acquisition, potentially impacting strategic timelines.
Competition: Increasing competition in private markets could challenge the company's ability to secure attractive investment opportunities.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Acquisition of SWK Holdings: Runway Growth Finance announced a definitive merger agreement to acquire SWK Holdings, a specialty finance company focused on healthcare and life sciences. The acquisition is expected to scale the portfolio by an estimated $242 million, expand investment capabilities in the healthcare and life sciences sector, and enhance earnings power and financial profile. The transaction is anticipated to close in early 2026, subject to regulatory approval.
Portfolio Diversification and Growth: The company plans to diversify its portfolio by increasing exposure to healthcare and life sciences, which will represent approximately 31% of the overall portfolio at fair value post-acquisition, up from 14%. The focus will remain on healthcare, technology, and select consumer sectors.
Earnings and Dividend Projections: The acquisition of SWK is expected to generate mid-single-digit run rate net investment income accretion during the first full quarter following the close, support modest ROE expansion, and improve dividend coverage. The company aims to maintain its dividend and enhance earnings power despite market challenges.
Leverage and Financial Efficiency: Post-acquisition, the leverage profile is expected to optimize at approximately 1.1x, the middle of the target range. The company anticipates greater expense efficiency due to increased scale.
Market Position and Strategy: Runway Growth Finance aims to solidify its position in the venture and growth lending markets through strategic acquisitions and portfolio optimization. The SWK transaction is seen as a repeatable and flexible blueprint for future growth.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Base Dividend: Runway Growth Finance declared a regular distribution for the fourth quarter of $0.33 per share on November 6, 2025.
Dividend Coverage: The company continues to cover its base dividend of $0.33 per share, delivering $0.43 of net investment income in the third quarter.
Spillover Income: At the end of the third quarter, the company had spillover income of approximately $0.53 per share.
Stock Repurchase Program: The Board of Directors approved a new stock repurchase program of $25 million on May 7, 2025, which will expire on May 7, 2026, or earlier if the total amount of stock authorized for repurchase is completed. During the third quarter, 397,983 shares were repurchased.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How should we think about origination activity and repayment activity in Q4 given the SWK merger's expected close date in 2026?
A:Repayments are expected to be relatively muted compared to Q3, as some repayments anticipated for Q4 occurred in Q3. Origination activity will utilize the existing pipeline and broader BC Partners Credit platform, with many interesting opportunities in the market.
Q:What is the yield profile between the existing portfolio and the SWK portfolio, and what is expected after integration?
A:The SWK portfolio has a slightly higher yield than the existing portfolio. Complete pro formas will be included in the N14 filing. There may be opportunities to upsize the best loans in the SWK portfolio for organic growth.
Q:Which portfolio companies were the main drivers of realized loss and unrealized portfolio depreciation?
A:The losses were mainly in the equity portfolio, driven by warrant expirations and liquidation of IPO shares at less than carrying cost. There was no specific theme, and most losses were idiosyncratic.
Q:What is driving prepayment activity, and is it expected to continue next year?
A:Prepayment activity is driven by active M&A across portfolio companies and some companies outgrowing the cost of capital and finding cheaper refinancing options. Normal course prepayments are expected to continue.
Q:What share of recent deals came from the BC Partners ecosystem, and how do these opportunities differ from the legacy pipeline?
A:There is a good split between deals from the BC Partners ecosystem and the legacy pipeline. Opportunities from BC Partners are firmly within the sectors of healthcare, technology, and select consumer, and meet the growth stage and structural return profile of the portfolio.
Q:What are the competitive dynamics and pricing pressures in the venture debt space currently?
A:There has been some spread compression, but it is less severe compared to the broader middle market and syndicated markets. As rates drop, there is less pressure on spreads, which is expected to continue.
Q:How do you plan to integrate the SWK team into your platform?
A:The SWK team will assist with transition services, portfolio relationships, and new originations during the transition period. Future roles will be determined after the transition.
Q:Are the SWK shareholders locked up post-merger, and what is the schedule of the lockups?
A:There is no specific lockup for SWK shareholders. A key shareholder agreement exists, and its elements are outlined in SEC filings.
Q:Why was the dividend set at $0.33 per share despite net investment income being $0.43 per share?
A:The dividend was set based on the portfolio's earnings power, considering anticipated prepayments and interest rate decreases. The Board aims to cover the base dividend with Q4 earnings as the portfolio rebuilds.
Q:Does the SWK team currently have the ability to make new loans, and do you have any say in those loans?
A:The SWK team operates under interim covenants as part of the merger agreement. Any loan modifications are reviewed with the investment committee, and new opportunities are likely to be joint or part of the runway portfolio.
Q:What are the characteristics of the loan added to the Cadma JV, and why was it a good fit for that vehicle?
A:The loan is a growth loan, similar to Runway loans, but better suited for the Cadma JV due to specific characteristics.
Q:What is the breakdown of PIK income, and how is it structured?
A:PIK income comprised 11.5% of total investment income. Structured PIK is often offered for 1-2 years, with some loans allowing 1-1.5% PIK for the loan's life. Loans are underwritten with a focus on loan-to-value, considering accrued PIK.
Q:Do you expect the SWK merger to be accretive in 2026?
A:Yes, the merger is expected to be accretive in the first full quarter after closing, which is anticipated early in Q1 2026.
Q:Will the investment assets of the acquired company be marked at fair value, and is there potential for OID accretion?
A:Yes, investment assets will be marked at fair value, and there is potential for OID accretion over time.
Q:Will shares be issued based on NAV per share or the current share price?
A:Shares will be issued based on a NAV-for-NAV merger, determined 48 hours before closing.
Q:What stage of development are the typical companies that SWK invests in?
A:SWK targets growth-stage companies generating meaningful revenue, mostly pre-profit, with strategic overlap and similar structural elements to the existing portfolio.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the breakdown of PIK income between structured and credit-related PIK, stating they did not have the numbers at their fingertips. Additionally, they used vague language when discussing the potential for OID accretion, indicating it is still under review.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Cadma
Journey Medical
King Insurance
Partners Credit
SKNV
SWK Holdings
SWK financing
SWK portfolio
SWK position
SkillShare
acquisition SWK
agreement SWK
completion investment
consolidation
consumer sector
dermatology
diversification position
healthcare life
industry
lever
life science
loan investment
merger agreement
portfolio activity
portfolio diversification
portfolio optimization
profile
reminder
risk return
science sector
sector transaction
sense
RWAY Transcript
Runway Growth Finance Corp. (RWAY) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call reveals several concerns: increased operational costs, credit downgrades, and a higher leverage ratio, all of which point to financial strain. Despite a new share repurchase program and the SWK acquisition's potential accretive impact, the negative outlook on earnings due to nonaccrual loans and reduced investment income overshadows positives. The NAV decline and portfolio depreciation further suggest a challenging environment. The Q&A does not alleviate these concerns, indicating a likely negative stock price movement in the next two weeks.
Runway Growth Finance Corp. (RWAY) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call reveals several negative financial trends: a decline in total investment income, net investment income, and portfolio value. While the acquisition of SWK Holdings and strategic plans are positive, the immediate financial performance is weak. The Q&A highlights cautious sentiment regarding leverage and challenges in building the Cadma JV portfolio. Although there are some positive developments, such as improved investment outcomes and strong liquidity, the overall sentiment is dampened by declining income and NAV, resulting in a negative outlook.
Runway Growth Finance Corp. (RWAY) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary indicates a positive sentiment overall, with strong financial performance, optimistic product development updates, and a shareholder return plan involving a stock repurchase program. Despite some muted market outlooks and competitive pressures, the Q&A section reflects a positive sentiment from analysts, especially regarding the SWK merger's accretive potential. The strategic plan and capital management efforts further support a positive outlook for the stock price in the short term.
Runway Growth Finance Corp. (RWAY) Q2 2025 Earnings Call Transcript
Unknown8-8
The earnings call shows mixed signals: strong liquidity and shareholder returns are positive, but there's a decrease in NAV per share and asset coverage. The Q&A reveals cautious management, with concerns over increased interest expenses and unclear guidance on JV benefits. Despite some positive developments like new products and strategic partnerships, the muted deal activity and management's cautious outlook suggest limited short-term stock price movement. Overall, these factors balance out, resulting in a neutral sentiment.
RWAY Slides
Runway Growth Q1 2026 slides: earnings miss amid SWK integration2026-05-07
Runway Growth Q4 2025 slides highlight expansion amid revenue miss2026-03-12
Runway Growth Finance Q3 2025 slides: Strategic acquisitions to boost portfolio amid yield compression2025-11-06
Runway Growth Finance Q2 2025 slides: portfolio stability and NAV growth amid market challenges2025-08-07
RWAY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
